Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma

C–C motif chemokine ligand 2 (CCL2) is a monocyte chemoattractant that promotes metastatic disease and portends a poor prognosis in many cancers. To determine the potential of anti-CCL2 inhibition as a therapy for recurrent metastatic disease in neuroblastoma, a mouse model of minimal residual disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lascano, Danny, Zobel, Michael J., Lee, William G., Chen, Stephanie Y., Zamora, Abigail, Asuelime, Grace E., Choi, So Yung, Chronopoulos, Antonios, Asgharzadeh, Shahab, Marachelian, Araz, Park, Jinseok, Sheard, Michael A., Kim, Eugene S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645976/
https://www.ncbi.nlm.nih.gov/pubmed/37964011
http://dx.doi.org/10.1038/s41598-023-46968-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645976/
https://www.ncbi.nlm.nih.gov/pubmed/37964011
http://dx.doi.org/10.1038/s41598-023-46968-2

Ejemplares similares